A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : ara-C

Search Conditions:
Search Keyword : ara-C
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 3 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: ara-C
Appearance Frequency: 817 time(s)
Long forms: 41

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
1-beta-D-arabinofuranosylcytosine
(660 times)
Neoplasms
(313 times)
HU (40 times)
ara-CTP (36 times)
AML (22 times)
1967 Nonidentiy of some simian virus 40-induced enzymes with tumor antigen.
arabinosylcytosine
(107 times)
Neoplasms
(39 times)
AML (7 times)
ara-U (6 times)
CLL (6 times)
1975 Pharmacologic studies of cyclocytidine and arabinosylcytosine in dogs.
analog cytarabine
(4 times)
Genomics
(1 time)
AML (3 times)
ara-CTP (2 times)
CDD (1 time)
2009 Genetic factors influencing cytarabine therapy.
arabinonucleoside
(4 times)
Science
(2 times)
GAPDH (2 times)
1987 Antigen-specific drug-targeting used to manipulate an immune response in vivo.
activity of cytarabine
(3 times)
Hematology
(2 times)
AML (3 times)
ALL (1 time)
CA (1 time)
2003 Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.
anthracycline plus cytarabine
(3 times)
Neoplasms
(2 times)
AML (3 times)
CR (3 times)
CRp (1 time)
2003 Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia.
arabinocide
(2 times)
Hematology
(2 times)
AML (1 time)
CR (1 time)
MPO (1 time)
1996 [Low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor for the treatment of relapsed acute myeloid leukemia].
1-beta-D-arabinofuranosylcytosine conjugates
(1 time)
Biochemistry
(1 time)
--- 1993 Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of optical isomers of ether and thioether lipids.
ability to modulate the cellular pharmacology of cytarabine
(1 time)
Antineoplastic Agents
(1 time)
--- 1982 Modulation of cytarabine metabolism in the human promyelocytic leukemia cell line HL-60 by polyhydroxy-substituted benzohydroxamic acids.
10  abnormalities is the type of leukemia most responsive to cytarabine
(1 time)
Neoplasms
(1 time)
AML (1 time)
CBF (1 time)
FA (1 time)
2008 Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.
11  acid L-histidine, improves the specificity of cytarabine
(1 time)
Neoplasms
(1 time)
FUra (1 time)
1985 Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
12  active form of cytarabine
(1 time)
Hematology
(1 time)
5NT (1 time)
AML (1 time)
CDD (1 time)
2002 In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.
13  active triphosphate of cytarabine
(1 time)
AML (1 time)
SAMHD1 (1 time)
2017 SAMHD1 is a barrier to antimetabolite-based cancer therapies.
14  activity pattern of cytarabine
(1 time)
Neoplasms
(1 time)
CdA (1 time)
FMCA (1 time)
1995 Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
15  addition of rituximab to high-dose cytarabine
(1 time)
Biology
(1 time)
R-DHAOx (1 time)
2010 Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma.
16  administration of methotrexate and cytarabine
(1 time)
Neurology
(1 time)
--- 2003 Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
17  Adriamycin and high-dose cytarabine
(1 time)
Neoplasms
(1 time)
ALL (1 time)
BMT (1 time)
CR (1 time)
1990 Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia.
18  after continuous infusion of high-dose cytarabine
(1 time)
Neoplasms
(1 time)
ANC (1 time)
ASLL (1 time)
EFS (1 time)
1998 Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study.
19  agent or when combined with cytarabine
(1 time)
Neoplasms
(1 time)
AML (1 time)
CR (1 time)
IA (1 time)
2003 Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia.
20  alkaline conditions that degrade
(1 time)
Biochemistry
(1 time)
--- 1980 Correlation of cytotoxicity with incorporation of ara-C into DNA.
21  allogeneic marrow transplant with cytarabine
(1 time)
Neoplasms
(1 time)
ALL (1 time)
ANL (1 time)
CML (1 time)
1988 High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.
22  alternated with high-dose cytarabine
(1 time)
Neoplasms
(1 time)
CODOX-M (1 time)
CSFs (1 time)
GM (1 time)
1996 Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.
23  alternates hyperfractionated doses of cyclophosphamide with high-dose cytarabine
(1 time)
Neoplasms
(1 time)
ALL (1 time)
BMT (1 time)
Ph (1 time)
1994 Management of adult acute lymphocytic leukemia: present issues and key challenges.
24  Although replication of nuclear DNA is inhibited by cytarabine
(1 time)
Neoplasms
(1 time)
ATP (1 time)
1987 Influence of cytarabine on mitochondrial function and mitochondrial biogenesis.
25  amsacrine and high-dose cytosine arabinoside
(1 time)
Hematology
(1 time)
ALL (1 time)
AML (1 time)
CR (1 time)
1994 Characteristics and outcome of patients with acute lymphocytic leukemia and myeloperoxidase-positive blasts by electron microscopy.
26  analogs such as cytarabine
(1 time)
Drug Therapy
(1 time)
ara-CTP (1 time)
dCK (1 time)
SNP (1 time)
2007 Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants.
27  analysis of cytarabine
(1 time)
Chemistry Techniques, Analytical
(1 time)
ESI (1 time)
HPLC (1 time)
MS/MS (1 time)
2007 Porous graphitic carbon chromatography/tandem mass spectrometric determination of cytarabine in mouse plasma.
28  animals have demonstrated synergistic cytotoxicity of cytarabine
(1 time)
Antineoplastic Agents
(1 time)
--- 1984 Phase I clinical evaluation of cytarabine and cisplatin in patients with advanced cancer.
29  antagonist that is structurally related to cytarabine
(1 time)
Neoplasms
(1 time)
NSCLC (1 time)
2002 Hypersensitivity pneumonitis in advanced non-small-cell lung cancer patients receiving gemcitabine and paclitaxel: report of two cases and a review of the literature.
30  anthracycline and cytosine arbinoside
(1 time)
Neoplasms
(1 time)
--- 1988 In vitro sensitivity of clonogenic cells in resisting and relapsing patients with acute myelogenous leukaemia.
31  anti-tumour agent of cytarabine
(1 time)
Biochemistry
(1 time)
--- 2009 Radiolytic activation of a cytarabine prodrug possessing a 2-oxoalkyl group: one-electron reduction and cytotoxicity characteristics.
32  anticancer prodrug cytarabine
(1 time)
Science
(1 time)
PCNA (1 time)
2018 Superresolution imaging of individual replication forks reveals unexpected prodrug resistance mechanism.
33  antiproliferative activity of cytarabine
(1 time)
Hematology
(1 time)
IFN (1 time)
1992 Effects of recombinant human interferon-alpha, beta and gamma on the antiproliferative activity of cytarabine in K562 human myeloid leukemia clonogenic cells.
34  ara-CTP formation or
(1 time)
Neoplasms
(1 time)
pRb (1 time)
1999 Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
35  aracytin
(1 time)
Neoplasms
(1 time)
GCV (1 time)
HSV-TK (1 time)
MTX (1 time)
2011 Improved retroviral suicide gene transfer in colon cancer cell lines after cell synchronization with methotrexate.
36  assess cytarabine
(1 time)
Genetics, Medical
(1 time)
CDA (1 time)
2011 Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells.
37  associated with formation of less
(1 time)
Neoplasms
(1 time)
ara-A (1 time)
HSV (1 time)
1984 Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
38  attempts to protect hematopoietic progenitor cells from cytarabine
(1 time)
Neoplasms
(1 time)
CDD (1 time)
1998 Assessment of resistance induction to cytosine arabinoside following transfer and overexpression of the deoxycytidylate deaminase gene in vitro.
39  augment conventional cytarabine
(1 time)
Neoplasms
(1 time)
AML (1 time)
2015 The NEDD8-activating enzyme inhibitor MLN4924 disrupts nucleotide metabolism and augments the efficacy of cytarabine.
40  cytosine-B-D-arabinofuranoside hydrochloride
(1 time)
Brain
(1 time)
BUdR (1 time)
DIV (1 time)
1976 Effect of 5-bromo-2'-deoxyuridine or cytosine-B-D-arabinofuranoside hydrochloride on myelination in newborn rat cerebellum cultures following removal of myelination inhibiting antiserum to whole cord or cerebroside.
41  review are cytarabine
(1 time)
Neoplasms
(1 time)
--- 2002 [Clinical pharmacology of nucleoside analogues].